Royal London Asset Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10M | Buy |
37,606
+988
| +3% | +$268K | 0.02% | 454 |
|
|
2025
Q4 | $9.19M | Buy |
36,618
+168
| +0.5% | +$44.6K | 0.02% | 463 |
|
|
2025
Q3 | $10.5M | Sell |
36,450
-2,124
| -6% | -$569K | 0.02% | 435 |
|
|
2025
Q2 | $10.1M | Sell |
38,574
-267
| -0.7% | -$65K | 0.02% | 446 |
|
|
2025
Q1 | $9.04M | Buy |
38,841
+4,464
| +13% | +$1.08M | 0.02% | 456 |
|
|
2024
Q4 | $7.88M | Sell |
34,377
-216
| -0.6% | -$49.6K | 0.02% | 462 |
|
|
2024
Q3 | $7.73M | Buy |
34,593
+1,437
| +4% | +$316K | 0.02% | 472 |
|
|
2024
Q2 | $6.75M | Sell |
33,156
-4,390
| -12% | -$893K | 0.02% | 473 |
|
|
2024
Q1 | $8.2M | Sell |
37,546
-1,280
| -3% | -$282K | 0.02% | 438 |
|
|
2023
Q4 | $8.82M | Buy |
38,826
+4,682
| +14% | +$984K | 0.03% | 410 |
|
|
2023
Q3 | $6.86M | Sell |
34,144
-3,162
| -8% | -$667K | 0.02% | 439 |
|
|
2023
Q2 | $6.64M | Hold |
37,306
| – | – | 0.02% | 437 |
|
|
2023
Q1 | $7.35M | Sell |
37,306
-1,170
| -3% | -$241K | 0.03% | 387 |
|
|
2022
Q4 | $7.78M | Hold |
38,476
| – | – | 0.03% | 367 |
|
|
2022
Q3 | $6.77M | Sell |
38,476
-3,834
| -9% | -$785K | 0.03% | 367 |
|
|
2022
Q2 | $8.52M | Hold |
42,310
| – | – | 0.04% | 334 |
|
|
2022
Q1 | $9.58M | Buy |
42,310
+1,032
| +3% | +$243K | 0.04% | 341 |
|
|
2021
Q4 | $11.1M | Hold |
41,278
| – | – | 0.04% | 322 |
|
|
2021
Q3 | $9.98M | Sell |
41,278
-751
| -2% | -$189K | 0.04% | 329 |
|
|
2021
Q2 | $9.96M | Hold |
42,029
| – | – | 0.04% | 335 |
|
|
2021
Q1 | $9.21M | Buy |
42,029
+1,840
| +5% | +$369K | 0.04% | 330 |
|
|
2020
Q4 | $7.03M | Sell |
40,189
-1,088
| -3% | -$188K | 0.04% | 349 |
|
|
2020
Q3 | $6.61M | Hold |
41,277
| – | – | 0.04% | 338 |
|
|
2020
Q2 | $5.75M | Sell |
41,277
-1,813
| -4% | -$251K | 0.04% | 354 |
|
|
2020
Q1 | $4.88M | Hold |
43,090
| – | – | 0.04% | 370 |
|
|
2019
Q4 | $6.23M | Sell |
43,090
-1,499
| -3% | -$216K | 0.04% | 360 |
|
|
2019
Q3 | $6.44M | Hold |
44,589
| – | – | 0.05% | 345 |
|
|
2019
Q2 | $6.62M | Sell |
44,589
-1,443
| -3% | -$201K | 0.06% | 291 |
|
|
2019
Q1 | $6.05M | Sell |
46,032
-39,715
| -46% | -$4.89M | 0.05% | 370 |
|
|
2018
Q4 | $9.17M | Buy |
85,747
+13,649
| +19% | +$1.83M | 0.08% | 251 |
|
|
2018
Q3 | $10.8M | Sell |
72,098
-1,107
| -2% | -$168K | 0.11% | 193 |
|
|
2018
Q2 | $11.3M | Buy |
+73,205
| New | +$11.1M | 0.11% | 194 |
|
|
2016
Q2 | $4.39M | Sell |
39,204
-3,331,475
| -99% | -$359M | 0.07% | 283 |
|
|
2016
Q1 | $25K | Buy |
3,370,679
+3,328,809
| +7,950% | +$319M | 0.04% | 438 |
|
|
2015
Q4 | $4.47M | Buy |
41,870
+620
| +2% | +$64K | 0.07% | 299 |
|
|
2015
Q3 | $3.84M | Buy |
+41,250
| New | +$4.27M | 0.06% | 329 |
|
|
2014
Q4 | $59K | Buy |
62,676
+4,673
| +8% | +$413K | 0.11% | 212 |
|
|
2014
Q3 | $5.14M | Buy |
58,003
+989
| +2% | +$89.4K | 0.13% | 179 |
|
|
2014
Q2 | $5.04M | Sell |
57,014
-1,066
| -2% | -$92.3K | 0.12% | 196 |
|
|
2014
Q1 | $4.98M | Buy |
58,080
+32,848
| +130% | +$2.62M | 0.12% | 199 |
|
|
2013
Q4 | $1.99M | Sell |
25,232
-101
| -0.4% | -$8.61K | 0.05% | 394 |
|
|
2013
Q3 | $2.18M | Buy |
25,333
+177
| +0.7% | +$14.9K | 0.06% | 360 |
|
|
2013
Q2 | $2.18M | Buy |
+25,156
| New | +$2.09M | 0.06% | 341 |
|
Other funds holding LH
VCM
VPM
Royal London Asset Management's LH Position: Q1 2026 in Review
Royal London Asset Management increased its Labcorp (LH) stake by 2.7% in Q1 2026, buying an estimated $268K and bringing the position to 37,606 shares worth $10M. The position accounts for 0.02% of the portfolio, ranked #454.
Royal London Asset Management first reported a position in LH in Q2 2013 and has held it in 43 quarters since. The position peaked at $11.3M in Q2 2018. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Royal London Asset Management held 37,606 shares of Labcorp worth $10M as of Q1 2026.
- Royal London Asset Management bought 988 Labcorp shares in Q1 2026, an estimated $268K.
- Labcorp made up 0.02% of Royal London Asset Management's portfolio in Q1 2026, its #454 holding.
- Royal London Asset Management first reported a position in Labcorp in Q2 2013 and has held it in 43 quarters since.
- Royal London Asset Management's Labcorp position peaked at $11.3M in Q2 2018.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Royal London Asset Management's 13F filing for Q1 2026, filed 1 May 2026.